article
3 December 2015 | By Claire Strain-Damerell (Structural Genomics Consortium), Michelle Hill (University of Queensland), Nicola Burgess-Brown (Structural Genomics Consortium), Pravin Mahajan (Structural Genomics Consortium), Rod Chalk (Structural Genomics Consortium)
In this Mass Spectrometry In-Depth Focus: Michelle M. Hill from University of Queensland discusses Mass spectrometric and systems biology approaches in drug target discovery, and Nicola Burgess-Brown, Rod Chalk, Claire Strain-Damerell and Pravin Mahajan from the Structural Genomics Consortium look at analysing recombinant proteins by mass spectrometry...